Preparation of wheat cysteine protease triticain-alpha produced in soluble form and method of producing same

Abstract

The invention relates to the field of molecular biology, preparative biochemistry, biotechnology, and biopharmacology, namely to the creation of recombinant proteins of the family of wheat (Triticum aestivum) cysteine proteases in soluble form, and preparations of the protein triticain-alpha consisting of a fragment of wheat triticain-alpha and methods for the production thereof. The invention can be used for research purposes to study the functioning of papain-like cysteine proteases, as well as in medicine for developing therapeutic enzyme preparations, and is a method of producing, in soluble form, recombinant functionally active variants of wheat (Triticum aestivum) cysteine proteases, including the engineering of plasmid DNA for cloning in expression systems of E. coli and P. Pastoris. By transforming cells of E. coli of the strain Rossetta gami B (DE3) and cells of P. pastoris of the strain GS115 by plasmid DNA pET15-6HIS-tritcain-α-GM, pET15-triticain-α-GM-6HIS, and pPIC9-triticain-α-GM respectively, truncated producing strains of wheat triticain-alpha are obtained, with subsequent culturing of host cells, separation of expressing protein, and purification by chromatographic methods. The invention allows variants of a biologically active fragment of wheat protease to be produced in soluble form in bacteria and yeast expression systems and allows the preparation triticain-alpha to be produced with a high, stable output, purity level and functional activity.

Dependencies are inferred from the claim text.